GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's ...

To test the sensor accuracy, the researchers implanted it onto the skin of a hairless diabetic ... Forlenza does research with Medtronic and Dexcom, which both manufacture blood glucose monitoring ...

Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient and ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient ...

Morningstar brands and products Company Portfolio ...